Fox Biosystems has announced the launch of its White Fox biosensor, developed through recent collaborations with scientists and engineers on a range of EU projects.
The White Fox’s fibre-optic probe setup combines a fluidics-free dip-in protocol with the precision and speed of SPR, the company says. This approach is designed to reduce the risk of clogging when using complex samples such as lysates, whole blood or large particles. The probes use a generic surface chemistry and can be switched to allow the detection of different target molecules, including antibodies, nanobodies, microvesicles, phage and small molecule.
The device is suitable for applications including kinetic affinity analysis, label free biomolecule quantification and fast specific and ultra-sensitive sandwich assays, even with complex samples.
Thomas van Elzakker, CEO of Fox Biosystem said: “I am very proud of our team’s achievement in creating an all-in-one, easy-to-use benchtop instrument that can overcome current limitations in bioanalytics. Our new White FOx not only offers a convenient solution to many of today’s challenges but will also be key in revealing new data, helping scientists to reach their goals more quickly. For this, I am grateful to our investors, collaborators and highly motivated team.”
